Swiss National Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $5.86M | Hold |
|
|||||
2024
Q1 | $6.05M | Buy |
|
|||||
2023
Q4 | $5.92M | Buy |
|
|||||
2023
Q3 | $3.01M | Buy |
|
|||||
2023
Q2 | $4.34M | Buy |
|
|||||
2023
Q1 | $3.29M | Sell |
|
|||||
2022
Q4 | $4.75M | Buy |
|
|||||
2022
Q3 | $3.98M | Buy |
|
|||||
2022
Q2 | $3.67M | Buy |
|
|||||
2022
Q1 | $3.65M | Buy |
|
|||||
2021
Q4 | $3.1M | Buy |
|
|||||
2021
Q3 | $2.75M | Buy |
|
|||||
2021
Q2 | $1.8M | Buy |
|